S0031, ZD 1839 in Treating Patients With Advanced Cancer of the Urinary Tract

NCT00014144 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

31

Enrollment

NETWORK

Sponsor class

Conditions

Bladder Cancer
Transitional Cell Cancer of the Renal Pelvis and Ureter
Urethral Cancer

Interventions

DRUG: gefitinib

Sponsor

SWOG Cancer Research Network

Collaborators

[object Object]